Atrial Fibrillation Device Market: Segmentation
Atrial Fibrillation Device Market Analysis
Atrial Fibrillation Device Market: Global Industry Analysis and Opportunity Assessment 2016-2026
- Healthcare, Pharmaceuticals and Medical devices
- Ongoing
- August 2019
- REP-GB-2214
-
Atrial fibrillation is a type of arrhythmias refers to as an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Atrial fibrillation may lead to blood cloth, heart failure, strokes and other heart related problems. If atrial fibrillation disease remains untreated it will double the risk of patient’s death. Valvular heart disease and hypertension are the most common alterablerisk factor of atrial fibrillation disease. In 2014, according to centers for disease control and prevention, around 6 Mn people in the U.S were suffering from atrial fibrillation disease and the number was estimated to increase in near future. According to MRI Interventions, Inc. research report, around 2 to 4 Mn new patients are diagnosed with atrial fibrillation in the U.S annually and the incidence rate of atrial fibrillation disease will increase. Technological advancement in the field of surgical catheter ablation along with rising occurrence of disease due to changes lifestyle habits like drinking and smoking will drive the growth of global atrial fibrillation device market in forecast period.
Atrial fibrillation is a type of arrhythmias refers to as an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Atrial fibrillation may lead to blood cloth, heart failure, strokes and other heart related problems. If atrial fibrillation disease remains untreated it will double the risk of patient’s death. Valvular heart disease and hypertension are the most common alterablerisk factor of atrial fibrillation disease. In 2014, according to centers for disease control and prevention, around 6 Mn people in the U.S were suffering from atrial fibrillation disease and the number was estimated to increase in near future. According to MRI Interventions, Inc. research report, around 2 to 4 Mn new patients are diagnosed with atrial fibrillation in the U.S annually and the incidence rate of atrial fibrillation disease will increase. Technological advancement in the field of surgical catheter ablation along with rising occurrence of disease due to changes lifestyle habits like drinking and smoking will drive the growth of global atrial fibrillation device market in forecast period.
Atrial Fibrillation Device Market: Drivers and Restraints
Market Growth Analysis
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Looking for the growth trajectory of this market? Give us an opportunity to help
Atrial Fibrillation Device Market:
Global Industry Analysis and Opportunity Assessment 2016-2026
Global Industry Analysis and Opportunity Assessment 2016-2026
EXPLORE THE FULL REPORT
/p>
The global atrial fibrillation device market has been classified on the basis of surgical type, non-surgical and end user.
Atrial Fibrillation Device Market: Overview
Atrial Fibrillation Device Market: Regional Overview
Atrial Fibrillation Device Market: Key Players
Some of the key players in global atrial fibrillation device market are Boston Scientific Corporation, Abbott, Biosense Webster, Inc., St. Jude Medical, Inc., Siemens Healthcare, Medtronic plc, Koninklijke Philips N.V. and AtriCure, Inc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
Competitive Positioning Matrix
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Looking for market shares of key players? Get in touch with the author(s)Region-wise Growth Analysis
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Send me the region-wise analysis for this reportIncrease in the prevalence of obesity and hypertension among aging population, reduce mortality rate and favorable outcomes of the atrial fibrillation device are the factors expected to drive the growth of global atrial fibrillation device market. Moreover, atrial fibrillation device is an alternative to long term oral anticoagulants among non-valvular atrial fibrillation (NVAF) patients, eliminate the use of long term warfarin and reduce the risk of heart bleeding and strokes are some other factors expected to fuel the growth of global atrial fibrillation device market. However, alternative to atrial fibrillation device such as drug therapy, catheter related complications and high cost of minimally invasive ablation procedures are proving a major challenge for overall growth of atrial fibrillation device market.
Atrial Fibrillation Device Market: Segmentation
Based on surgical type, the global atrial fibrillation device market is divided into following:
- Catheter Ablation
- Maze Surgery
Based on non-surgical, the global atrial fibrillation device market is divided into following:
- Pharmacological Drugs
- Diagnostic devices
- Electric Cardioversion
- Recording Systems
- Access Devices
- Cardiac Monitors
- Closure Devices
- Left Atrial Appendage
Based on end user, the global atrial fibrillation device market is divided into following:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
Based on surgical type, global atrial fibrillation device market is sub segmented into catheter ablation and diagnostic device, of which catheter ablation segment is expected to grow fastest over the forecast period. Increasing patient awareness, improved healthcare infrastructure and rising demand for non-pharmacological treatments are some of the factors which are driving the growth of catheter ablation segment. Pharmacological drug segment is expected to have highest market share in the forecast period. Low prices of pharmacological drugs along with increasing use of anti-coagulant therapy is driving the demand of pharmacological drugs segment.
Atrial Fibrillation Device Market: Regional Overview
Depending on geographic region, atrial fibrillation device market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America held largest share in the atrial fibrillation device market followed by Europe, Japan and Asia Pacific owing to high prevalence of atrial fibrillation, awareness among population, reimbursement policies,and healthcare infrastructure. The developing nations in Asia Pacific, Middle East and Africa hold huge potential for growth in the atrial fibrillation device market due to increase in geriatric population, improved healthcare expenditure along with increased per capita income. Also, growth in public and private hospitals, pharmacies & drug stores will drive the growth ofatrial fibrillation device market in this region.
Atrial Fibrillation Device Market: Key Players
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
